nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—ankylosing spondylitis—osteoporosis	0.623	1	CtDrD
Triamcinolone—PTGS2—Risedronate—osteoporosis	0.126	0.548	CbGbCtD
Triamcinolone—CYP3A4—Estropipate—osteoporosis	0.0189	0.082	CbGbCtD
Triamcinolone—CYP3A4—Calcitriol—osteoporosis	0.0189	0.082	CbGbCtD
Triamcinolone—CYP3A4—Ergocalciferol—osteoporosis	0.0151	0.0656	CbGbCtD
Triamcinolone—CYP3A4—Raloxifene—osteoporosis	0.0126	0.0547	CbGbCtD
Triamcinolone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0122	0.0529	CbGbCtD
Triamcinolone—CYP3A4—Cholecalciferol—osteoporosis	0.00972	0.0423	CbGbCtD
Triamcinolone—CYP3A4—Conjugated Estrogens—osteoporosis	0.00892	0.0388	CbGbCtD
Triamcinolone—CYP3A4—Estradiol—osteoporosis	0.00783	0.0341	CbGbCtD
Triamcinolone—Testolactone—CYP19A1—osteoporosis	0.000479	0.314	CrCbGaD
Triamcinolone—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.00044	0.0363	CbGpPWpGaD
Triamcinolone—Fluoxymesterone—SHBG—osteoporosis	0.000329	0.215	CrCbGaD
Triamcinolone—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000328	0.0271	CbGpPWpGaD
Triamcinolone—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—osteoporosis	0.000241	0.0199	CbGpPWpGaD
Triamcinolone—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—osteoporosis	0.000234	0.0193	CbGpPWpGaD
Triamcinolone—Fluoxymesterone—ESR1—osteoporosis	0.000222	0.145	CrCbGaD
Triamcinolone—BCHE—Glycerophospholipid biosynthesis—MGLL—osteoporosis	0.00022	0.0182	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—PRDX3—osteoporosis	0.0002	0.0165	CbGpPWpGaD
Triamcinolone—Hydrocortisone—SHBG—osteoporosis	0.0002	0.131	CrCbGaD
Triamcinolone—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—osteoporosis	0.000199	0.0165	CbGpPWpGaD
Triamcinolone—Betamethasone—CYP19A1—osteoporosis	0.000188	0.123	CrCbGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.000182	0.015	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.000181	0.015	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000178	0.0147	CbGpPWpGaD
Triamcinolone—BCHE—Peptide hormone metabolism—REN—osteoporosis	0.000172	0.0142	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.00016	0.0132	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.000159	0.0131	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.000155	0.0128	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—MGLL—osteoporosis	0.000154	0.0127	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.000152	0.0126	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	0.000151	0.0125	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptors—VDR—osteoporosis	0.000144	0.0119	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000143	0.0118	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000143	0.0118	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	0.000135	0.0111	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.000134	0.0111	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	0.000122	0.0101	CbGpPWpGaD
Triamcinolone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	0.000119	0.00983	CbGpPWpGaD
Triamcinolone—Fatigue—Ibandronate—osteoporosis	0.000119	0.000889	CcSEcCtD
Triamcinolone—Syncope—Pamidronate—osteoporosis	0.000119	0.000888	CcSEcCtD
Triamcinolone—Myalgia—Risedronate—osteoporosis	0.000119	0.000887	CcSEcCtD
Triamcinolone—Dysgeusia—Zoledronate—osteoporosis	0.000118	0.000886	CcSEcCtD
Triamcinolone—Pain—Ibandronate—osteoporosis	0.000118	0.000882	CcSEcCtD
Triamcinolone—Pruritus—Etidronic acid—osteoporosis	0.000118	0.00088	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Estradiol—osteoporosis	0.000118	0.000879	CcSEcCtD
Triamcinolone—Back pain—Zoledronate—osteoporosis	0.000117	0.000875	CcSEcCtD
Triamcinolone—Myocardial infarction—Estradiol—osteoporosis	0.000117	0.000874	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Estradiol—osteoporosis	0.000117	0.000874	CcSEcCtD
Triamcinolone—Feeling abnormal—Alendronate—osteoporosis	0.000117	0.000873	CcSEcCtD
Triamcinolone—Oedema—Ethinyl Estradiol—osteoporosis	0.000117	0.000872	CcSEcCtD
Triamcinolone—Erythema—Conjugated Estrogens—osteoporosis	0.000116	0.000871	CcSEcCtD
Triamcinolone—Loss of consciousness—Pamidronate—osteoporosis	0.000116	0.00087	CcSEcCtD
Triamcinolone—Dry mouth—Risedronate—osteoporosis	0.000116	0.000867	CcSEcCtD
Triamcinolone—Conjunctivitis—Estradiol—osteoporosis	0.000116	0.000867	CcSEcCtD
Triamcinolone—Infection—Ethinyl Estradiol—osteoporosis	0.000116	0.000866	CcSEcCtD
Triamcinolone—Cough—Pamidronate—osteoporosis	0.000116	0.000864	CcSEcCtD
Triamcinolone—Pain—Calcitriol—osteoporosis	0.000115	0.000864	CcSEcCtD
Triamcinolone—Convulsion—Pamidronate—osteoporosis	0.000115	0.000858	CcSEcCtD
Triamcinolone—Hypertension—Pamidronate—osteoporosis	0.000114	0.000855	CcSEcCtD
Triamcinolone—Urticaria—Estropipate—osteoporosis	0.000114	0.000855	CcSEcCtD
Triamcinolone—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000114	0.000853	CcSEcCtD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000114	0.00939	CbGpPWpGaD
Triamcinolone—Body temperature increased—Estropipate—osteoporosis	0.000114	0.00085	CcSEcCtD
Triamcinolone—Feeling abnormal—Ibandronate—osteoporosis	0.000114	0.00085	CcSEcCtD
Triamcinolone—Infection—Risedronate—osteoporosis	0.000113	0.000845	CcSEcCtD
Triamcinolone—Myalgia—Pamidronate—osteoporosis	0.000113	0.000843	CcSEcCtD
Triamcinolone—Back pain—Conjugated Estrogens—osteoporosis	0.000113	0.000842	CcSEcCtD
Triamcinolone—Urticaria—Alendronate—osteoporosis	0.000113	0.000842	CcSEcCtD
Triamcinolone—Epistaxis—Estradiol—osteoporosis	0.000112	0.000841	CcSEcCtD
Triamcinolone—Ill-defined disorder—Zoledronate—osteoporosis	0.000112	0.000839	CcSEcCtD
Triamcinolone—Body temperature increased—Alendronate—osteoporosis	0.000112	0.000838	CcSEcCtD
Triamcinolone—Shock—Risedronate—osteoporosis	0.000112	0.000836	CcSEcCtD
Triamcinolone—Discomfort—Pamidronate—osteoporosis	0.000111	0.000833	CcSEcCtD
Triamcinolone—Angioedema—Zoledronate—osteoporosis	0.00011	0.000827	CcSEcCtD
Triamcinolone—Body temperature increased—Raloxifene—osteoporosis	0.00011	0.000824	CcSEcCtD
Triamcinolone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	0.00011	0.00908	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptors—ESR1—osteoporosis	0.00011	0.00908	CbGpPWpGaD
Triamcinolone—Urticaria—Ibandronate—osteoporosis	0.00011	0.00082	CcSEcCtD
Triamcinolone—Dexamethasone—CYP19A1—osteoporosis	0.000109	0.0716	CrCbGaD
Triamcinolone—Malaise—Zoledronate—osteoporosis	0.000109	0.000816	CcSEcCtD
Triamcinolone—Body temperature increased—Ibandronate—osteoporosis	0.000109	0.000816	CcSEcCtD
Triamcinolone—Vertigo—Zoledronate—osteoporosis	0.000109	0.000813	CcSEcCtD
Triamcinolone—Syncope—Zoledronate—osteoporosis	0.000108	0.000811	CcSEcCtD
Triamcinolone—Anaphylactic shock—Pamidronate—osteoporosis	0.000108	0.000808	CcSEcCtD
Triamcinolone—Oedema—Pamidronate—osteoporosis	0.000108	0.000808	CcSEcCtD
Triamcinolone—Haemoglobin—Estradiol—osteoporosis	0.000108	0.000805	CcSEcCtD
Triamcinolone—Infection—Pamidronate—osteoporosis	0.000107	0.000803	CcSEcCtD
Triamcinolone—Rhinitis—Estradiol—osteoporosis	0.000107	0.000803	CcSEcCtD
Triamcinolone—Urticaria—Calcitriol—osteoporosis	0.000107	0.000802	CcSEcCtD
Triamcinolone—BCHE—Peptide hormone metabolism—ACE—osteoporosis	0.000107	0.00885	CbGpPWpGaD
Triamcinolone—Haemorrhage—Estradiol—osteoporosis	0.000107	0.000801	CcSEcCtD
Triamcinolone—Body temperature increased—Calcitriol—osteoporosis	0.000107	0.000798	CcSEcCtD
Triamcinolone—Angioedema—Conjugated Estrogens—osteoporosis	0.000106	0.000796	CcSEcCtD
Triamcinolone—Shock—Pamidronate—osteoporosis	0.000106	0.000795	CcSEcCtD
Triamcinolone—Loss of consciousness—Zoledronate—osteoporosis	0.000106	0.000795	CcSEcCtD
Triamcinolone—Pharyngitis—Estradiol—osteoporosis	0.000106	0.000795	CcSEcCtD
Triamcinolone—Hypersensitivity—Estropipate—osteoporosis	0.000106	0.000793	CcSEcCtD
Triamcinolone—Vomiting—Etidronic acid—osteoporosis	0.000106	0.000791	CcSEcCtD
Triamcinolone—Cough—Zoledronate—osteoporosis	0.000106	0.000789	CcSEcCtD
Triamcinolone—Tachycardia—Pamidronate—osteoporosis	0.000105	0.000789	CcSEcCtD
Triamcinolone—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	0.000105	0.00868	CbGpPWpGaD
Triamcinolone—Rash—Etidronic acid—osteoporosis	0.000105	0.000784	CcSEcCtD
Triamcinolone—Convulsion—Zoledronate—osteoporosis	0.000105	0.000784	CcSEcCtD
Triamcinolone—Dermatitis—Etidronic acid—osteoporosis	0.000105	0.000783	CcSEcCtD
Triamcinolone—Vertigo—Conjugated Estrogens—osteoporosis	0.000105	0.000783	CcSEcCtD
Triamcinolone—Hyperhidrosis—Pamidronate—osteoporosis	0.000104	0.000781	CcSEcCtD
Triamcinolone—Syncope—Conjugated Estrogens—osteoporosis	0.000104	0.000781	CcSEcCtD
Triamcinolone—Hypertension—Zoledronate—osteoporosis	0.000104	0.000781	CcSEcCtD
Triamcinolone—Hypersensitivity—Alendronate—osteoporosis	0.000104	0.000781	CcSEcCtD
Triamcinolone—Headache—Etidronic acid—osteoporosis	0.000104	0.000779	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000104	0.000775	CcSEcCtD
Triamcinolone—Asthenia—Estropipate—osteoporosis	0.000103	0.000772	CcSEcCtD
Triamcinolone—Myalgia—Zoledronate—osteoporosis	0.000103	0.00077	CcSEcCtD
Triamcinolone—Insomnia—Risedronate—osteoporosis	0.000103	0.000769	CcSEcCtD
Triamcinolone—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000102	0.000766	CcSEcCtD
Triamcinolone—Paraesthesia—Risedronate—osteoporosis	0.000102	0.000763	CcSEcCtD
Triamcinolone—Pruritus—Estropipate—osteoporosis	0.000102	0.000761	CcSEcCtD
Triamcinolone—Discomfort—Zoledronate—osteoporosis	0.000102	0.000761	CcSEcCtD
Triamcinolone—Asthenia—Alendronate—osteoporosis	0.000102	0.00076	CcSEcCtD
Triamcinolone—Hypersensitivity—Ibandronate—osteoporosis	0.000102	0.00076	CcSEcCtD
Triamcinolone—Cough—Conjugated Estrogens—osteoporosis	0.000102	0.00076	CcSEcCtD
Triamcinolone—Dyspnoea—Risedronate—osteoporosis	0.000101	0.000758	CcSEcCtD
Triamcinolone—Convulsion—Conjugated Estrogens—osteoporosis	0.000101	0.000755	CcSEcCtD
Triamcinolone—Dry mouth—Zoledronate—osteoporosis	0.000101	0.000753	CcSEcCtD
Triamcinolone—Fatigue—Ethinyl Estradiol—osteoporosis	0.0001	0.000752	CcSEcCtD
Triamcinolone—Pruritus—Alendronate—osteoporosis	0.0001	0.00075	CcSEcCtD
Triamcinolone—Dyspepsia—Risedronate—osteoporosis	0.0001	0.000748	CcSEcCtD
Triamcinolone—Hypersensitivity—Calcitriol—osteoporosis	9.95e-05	0.000744	CcSEcCtD
Triamcinolone—Myalgia—Conjugated Estrogens—osteoporosis	9.91e-05	0.000742	CcSEcCtD
Triamcinolone—Asthenia—Ibandronate—osteoporosis	9.89e-05	0.00074	CcSEcCtD
Triamcinolone—Nausea—Etidronic acid—osteoporosis	9.87e-05	0.000739	CcSEcCtD
Triamcinolone—Anaphylactic shock—Zoledronate—osteoporosis	9.87e-05	0.000738	CcSEcCtD
Triamcinolone—Oedema—Zoledronate—osteoporosis	9.87e-05	0.000738	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Pamidronate—osteoporosis	9.84e-05	0.000736	CcSEcCtD
Triamcinolone—Infection—Zoledronate—osteoporosis	9.8e-05	0.000733	CcSEcCtD
Triamcinolone—Fatigue—Risedronate—osteoporosis	9.8e-05	0.000733	CcSEcCtD
Triamcinolone—Insomnia—Pamidronate—osteoporosis	9.77e-05	0.000731	CcSEcCtD
Triamcinolone—Pruritus—Ibandronate—osteoporosis	9.76e-05	0.00073	CcSEcCtD
Triamcinolone—Pain—Risedronate—osteoporosis	9.72e-05	0.000727	CcSEcCtD
Triamcinolone—Shock—Zoledronate—osteoporosis	9.71e-05	0.000726	CcSEcCtD
Triamcinolone—Paraesthesia—Pamidronate—osteoporosis	9.7e-05	0.000726	CcSEcCtD
Triamcinolone—Asthenia—Calcitriol—osteoporosis	9.69e-05	0.000725	CcSEcCtD
Triamcinolone—Dyspnoea—Pamidronate—osteoporosis	9.63e-05	0.000721	CcSEcCtD
Triamcinolone—Tachycardia—Zoledronate—osteoporosis	9.63e-05	0.00072	CcSEcCtD
Triamcinolone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	9.61e-05	0.000719	CcSEcCtD
Triamcinolone—Pruritus—Calcitriol—osteoporosis	9.55e-05	0.000714	CcSEcCtD
Triamcinolone—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	9.54e-05	0.00788	CbGpPWpGaD
Triamcinolone—Hyperhidrosis—Zoledronate—osteoporosis	9.54e-05	0.000714	CcSEcCtD
Triamcinolone—Dyspepsia—Pamidronate—osteoporosis	9.51e-05	0.000711	CcSEcCtD
Triamcinolone—Dizziness—Estropipate—osteoporosis	9.51e-05	0.000711	CcSEcCtD
Triamcinolone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	9.5e-05	0.000711	CcSEcCtD
Triamcinolone—Oedema—Conjugated Estrogens—osteoporosis	9.5e-05	0.000711	CcSEcCtD
Triamcinolone—Infection—Conjugated Estrogens—osteoporosis	9.44e-05	0.000706	CcSEcCtD
Triamcinolone—Dizziness—Alendronate—osteoporosis	9.37e-05	0.000701	CcSEcCtD
Triamcinolone—Shock—Conjugated Estrogens—osteoporosis	9.35e-05	0.000699	CcSEcCtD
Triamcinolone—Erythema—Estradiol—osteoporosis	9.32e-05	0.000697	CcSEcCtD
Triamcinolone—Fatigue—Pamidronate—osteoporosis	9.31e-05	0.000697	CcSEcCtD
Triamcinolone—Tachycardia—Conjugated Estrogens—osteoporosis	9.27e-05	0.000694	CcSEcCtD
Triamcinolone—Urticaria—Ethinyl Estradiol—osteoporosis	9.26e-05	0.000693	CcSEcCtD
Triamcinolone—Pain—Pamidronate—osteoporosis	9.24e-05	0.000691	CcSEcCtD
Triamcinolone—Body temperature increased—Ethinyl Estradiol—osteoporosis	9.21e-05	0.000689	CcSEcCtD
Triamcinolone—Dizziness—Raloxifene—osteoporosis	9.21e-05	0.000689	CcSEcCtD
Triamcinolone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	9.19e-05	0.000687	CcSEcCtD
Triamcinolone—Vomiting—Estropipate—osteoporosis	9.14e-05	0.000684	CcSEcCtD
Triamcinolone—Dysgeusia—Estradiol—osteoporosis	9.13e-05	0.000683	CcSEcCtD
Triamcinolone—Dizziness—Ibandronate—osteoporosis	9.12e-05	0.000682	CcSEcCtD
Triamcinolone—Rash—Estropipate—osteoporosis	9.07e-05	0.000678	CcSEcCtD
Triamcinolone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	9.06e-05	0.00748	CbGpPWpGaD
Triamcinolone—Dermatitis—Estropipate—osteoporosis	9.06e-05	0.000678	CcSEcCtD
Triamcinolone—Urticaria—Risedronate—osteoporosis	9.03e-05	0.000675	CcSEcCtD
Triamcinolone—Back pain—Estradiol—osteoporosis	9.01e-05	0.000674	CcSEcCtD
Triamcinolone—Headache—Estropipate—osteoporosis	9.01e-05	0.000674	CcSEcCtD
Triamcinolone—Vomiting—Alendronate—osteoporosis	9.01e-05	0.000674	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Zoledronate—osteoporosis	8.99e-05	0.000673	CcSEcCtD
Triamcinolone—Body temperature increased—Risedronate—osteoporosis	8.98e-05	0.000672	CcSEcCtD
Triamcinolone—Rash—Alendronate—osteoporosis	8.93e-05	0.000668	CcSEcCtD
Triamcinolone—Insomnia—Zoledronate—osteoporosis	8.93e-05	0.000668	CcSEcCtD
Triamcinolone—Dermatitis—Alendronate—osteoporosis	8.92e-05	0.000667	CcSEcCtD
Triamcinolone—Feeling abnormal—Pamidronate—osteoporosis	8.9e-05	0.000666	CcSEcCtD
Triamcinolone—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	8.9e-05	0.00735	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—WNT1—osteoporosis	8.88e-05	0.00733	CbGpPWpGaD
Triamcinolone—Headache—Alendronate—osteoporosis	8.87e-05	0.000664	CcSEcCtD
Triamcinolone—Paraesthesia—Zoledronate—osteoporosis	8.86e-05	0.000663	CcSEcCtD
Triamcinolone—Vomiting—Raloxifene—osteoporosis	8.86e-05	0.000663	CcSEcCtD
Triamcinolone—Dyspnoea—Zoledronate—osteoporosis	8.8e-05	0.000658	CcSEcCtD
Triamcinolone—Rash—Raloxifene—osteoporosis	8.78e-05	0.000657	CcSEcCtD
Triamcinolone—Dermatitis—Raloxifene—osteoporosis	8.78e-05	0.000656	CcSEcCtD
Triamcinolone—Vomiting—Ibandronate—osteoporosis	8.77e-05	0.000656	CcSEcCtD
Triamcinolone—Headache—Raloxifene—osteoporosis	8.73e-05	0.000653	CcSEcCtD
Triamcinolone—Rash—Ibandronate—osteoporosis	8.7e-05	0.00065	CcSEcCtD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	8.69e-05	0.00717	CbGpPWpGaD
Triamcinolone—Dermatitis—Ibandronate—osteoporosis	8.69e-05	0.00065	CcSEcCtD
Triamcinolone—Dyspepsia—Zoledronate—osteoporosis	8.69e-05	0.00065	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	8.66e-05	0.000648	CcSEcCtD
Triamcinolone—Ill-defined disorder—Estradiol—osteoporosis	8.65e-05	0.000647	CcSEcCtD
Triamcinolone—Headache—Ibandronate—osteoporosis	8.64e-05	0.000646	CcSEcCtD
Triamcinolone—Insomnia—Conjugated Estrogens—osteoporosis	8.59e-05	0.000643	CcSEcCtD
Triamcinolone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	8.59e-05	0.000642	CcSEcCtD
Triamcinolone—Vomiting—Calcitriol—osteoporosis	8.58e-05	0.000642	CcSEcCtD
Triamcinolone—Nausea—Estropipate—osteoporosis	8.54e-05	0.000639	CcSEcCtD
Triamcinolone—Body temperature increased—Pamidronate—osteoporosis	8.54e-05	0.000639	CcSEcCtD
Triamcinolone—Paraesthesia—Conjugated Estrogens—osteoporosis	8.53e-05	0.000638	CcSEcCtD
Triamcinolone—Angioedema—Estradiol—osteoporosis	8.51e-05	0.000637	CcSEcCtD
Triamcinolone—Rash—Calcitriol—osteoporosis	8.51e-05	0.000637	CcSEcCtD
Triamcinolone—Fatigue—Zoledronate—osteoporosis	8.51e-05	0.000636	CcSEcCtD
Triamcinolone—Dermatitis—Calcitriol—osteoporosis	8.5e-05	0.000636	CcSEcCtD
Triamcinolone—Dyspnoea—Conjugated Estrogens—osteoporosis	8.47e-05	0.000634	CcSEcCtD
Triamcinolone—Headache—Calcitriol—osteoporosis	8.46e-05	0.000633	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	8.45e-05	0.00698	CbGpPWpGaD
Triamcinolone—Pain—Zoledronate—osteoporosis	8.44e-05	0.000631	CcSEcCtD
Triamcinolone—Nausea—Alendronate—osteoporosis	8.41e-05	0.000629	CcSEcCtD
Triamcinolone—Malaise—Estradiol—osteoporosis	8.4e-05	0.000629	CcSEcCtD
Triamcinolone—Hypersensitivity—Risedronate—osteoporosis	8.37e-05	0.000626	CcSEcCtD
Triamcinolone—Vertigo—Estradiol—osteoporosis	8.37e-05	0.000626	CcSEcCtD
Triamcinolone—Dyspepsia—Conjugated Estrogens—osteoporosis	8.36e-05	0.000626	CcSEcCtD
Triamcinolone—Asthenia—Ethinyl Estradiol—osteoporosis	8.36e-05	0.000626	CcSEcCtD
Triamcinolone—Syncope—Estradiol—osteoporosis	8.36e-05	0.000625	CcSEcCtD
Triamcinolone—Nausea—Raloxifene—osteoporosis	8.27e-05	0.000619	CcSEcCtD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	8.25e-05	0.00681	CbGpPWpGaD
Triamcinolone—Pruritus—Ethinyl Estradiol—osteoporosis	8.25e-05	0.000617	CcSEcCtD
Triamcinolone—Fatigue—Conjugated Estrogens—osteoporosis	8.19e-05	0.000613	CcSEcCtD
Triamcinolone—Nausea—Ibandronate—osteoporosis	8.19e-05	0.000613	CcSEcCtD
Triamcinolone—Loss of consciousness—Estradiol—osteoporosis	8.19e-05	0.000613	CcSEcCtD
Triamcinolone—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	8.16e-05	0.00673	CbGpPWpGaD
Triamcinolone—Asthenia—Risedronate—osteoporosis	8.15e-05	0.00061	CcSEcCtD
Triamcinolone—Feeling abnormal—Zoledronate—osteoporosis	8.13e-05	0.000608	CcSEcCtD
Triamcinolone—Cough—Estradiol—osteoporosis	8.13e-05	0.000608	CcSEcCtD
Triamcinolone—Pain—Conjugated Estrogens—osteoporosis	8.13e-05	0.000608	CcSEcCtD
Triamcinolone—Hypertension—Estradiol—osteoporosis	8.05e-05	0.000602	CcSEcCtD
Triamcinolone—Pruritus—Risedronate—osteoporosis	8.04e-05	0.000601	CcSEcCtD
Triamcinolone—NR3C1—Adipogenesis—BMP2—osteoporosis	8.03e-05	0.00663	CbGpPWpGaD
Triamcinolone—Nausea—Calcitriol—osteoporosis	8.02e-05	0.0006	CcSEcCtD
Triamcinolone—Hypersensitivity—Pamidronate—osteoporosis	7.96e-05	0.000595	CcSEcCtD
Triamcinolone—Myalgia—Estradiol—osteoporosis	7.93e-05	0.000593	CcSEcCtD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	7.85e-05	0.00648	CbGpPWpGaD
Triamcinolone—Urticaria—Zoledronate—osteoporosis	7.84e-05	0.000586	CcSEcCtD
Triamcinolone—Discomfort—Estradiol—osteoporosis	7.84e-05	0.000586	CcSEcCtD
Triamcinolone—Body temperature increased—Zoledronate—osteoporosis	7.8e-05	0.000584	CcSEcCtD
Triamcinolone—Dry mouth—Estradiol—osteoporosis	7.76e-05	0.00058	CcSEcCtD
Triamcinolone—Asthenia—Pamidronate—osteoporosis	7.75e-05	0.00058	CcSEcCtD
Triamcinolone—Dizziness—Ethinyl Estradiol—osteoporosis	7.71e-05	0.000577	CcSEcCtD
Triamcinolone—Pruritus—Pamidronate—osteoporosis	7.64e-05	0.000572	CcSEcCtD
Triamcinolone—Oedema—Estradiol—osteoporosis	7.61e-05	0.000569	CcSEcCtD
Triamcinolone—Anaphylactic shock—Estradiol—osteoporosis	7.61e-05	0.000569	CcSEcCtD
Triamcinolone—Infection—Estradiol—osteoporosis	7.56e-05	0.000565	CcSEcCtD
Triamcinolone—Urticaria—Conjugated Estrogens—osteoporosis	7.55e-05	0.000565	CcSEcCtD
Triamcinolone—Dizziness—Risedronate—osteoporosis	7.52e-05	0.000562	CcSEcCtD
Triamcinolone—Body temperature increased—Conjugated Estrogens—osteoporosis	7.51e-05	0.000562	CcSEcCtD
Triamcinolone—Shock—Estradiol—osteoporosis	7.48e-05	0.00056	CcSEcCtD
Triamcinolone—Tachycardia—Estradiol—osteoporosis	7.42e-05	0.000555	CcSEcCtD
Triamcinolone—Vomiting—Ethinyl Estradiol—osteoporosis	7.41e-05	0.000554	CcSEcCtD
Triamcinolone—Hyperhidrosis—Estradiol—osteoporosis	7.35e-05	0.00055	CcSEcCtD
Triamcinolone—Rash—Ethinyl Estradiol—osteoporosis	7.35e-05	0.00055	CcSEcCtD
Triamcinolone—Dermatitis—Ethinyl Estradiol—osteoporosis	7.34e-05	0.000549	CcSEcCtD
Triamcinolone—Headache—Ethinyl Estradiol—osteoporosis	7.3e-05	0.000546	CcSEcCtD
Triamcinolone—Hypersensitivity—Zoledronate—osteoporosis	7.27e-05	0.000544	CcSEcCtD
Triamcinolone—Vomiting—Risedronate—osteoporosis	7.23e-05	0.000541	CcSEcCtD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	7.2e-05	0.00594	CbGpPWpGaD
Triamcinolone—Rash—Risedronate—osteoporosis	7.17e-05	0.000536	CcSEcCtD
Triamcinolone—Dermatitis—Risedronate—osteoporosis	7.16e-05	0.000536	CcSEcCtD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	7.15e-05	0.00591	CbGpPWpGaD
Triamcinolone—Dizziness—Pamidronate—osteoporosis	7.14e-05	0.000534	CcSEcCtD
Triamcinolone—Headache—Risedronate—osteoporosis	7.12e-05	0.000533	CcSEcCtD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	7.1e-05	0.00586	CbGpPWpGaD
Triamcinolone—Asthenia—Zoledronate—osteoporosis	7.08e-05	0.00053	CcSEcCtD
Triamcinolone—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	7.03e-05	0.0058	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Conjugated Estrogens—osteoporosis	7e-05	0.000524	CcSEcCtD
Triamcinolone—Pruritus—Zoledronate—osteoporosis	6.98e-05	0.000522	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Estradiol—osteoporosis	6.93e-05	0.000518	CcSEcCtD
Triamcinolone—Nausea—Ethinyl Estradiol—osteoporosis	6.92e-05	0.000518	CcSEcCtD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.89e-05	0.00569	CbGpPWpGaD
Triamcinolone—Insomnia—Estradiol—osteoporosis	6.88e-05	0.000515	CcSEcCtD
Triamcinolone—Vomiting—Pamidronate—osteoporosis	6.87e-05	0.000514	CcSEcCtD
Triamcinolone—Paraesthesia—Estradiol—osteoporosis	6.83e-05	0.000511	CcSEcCtD
Triamcinolone—Asthenia—Conjugated Estrogens—osteoporosis	6.82e-05	0.00051	CcSEcCtD
Triamcinolone—Rash—Pamidronate—osteoporosis	6.81e-05	0.00051	CcSEcCtD
Triamcinolone—Dermatitis—Pamidronate—osteoporosis	6.81e-05	0.000509	CcSEcCtD
Triamcinolone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	6.78e-05	0.0056	CbGpPWpGaD
Triamcinolone—Dyspnoea—Estradiol—osteoporosis	6.78e-05	0.000507	CcSEcCtD
Triamcinolone—Headache—Pamidronate—osteoporosis	6.77e-05	0.000506	CcSEcCtD
Triamcinolone—Nausea—Risedronate—osteoporosis	6.75e-05	0.000505	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	6.74e-05	0.00557	CbGpPWpGaD
Triamcinolone—Pruritus—Conjugated Estrogens—osteoporosis	6.72e-05	0.000503	CcSEcCtD
Triamcinolone—Dyspepsia—Estradiol—osteoporosis	6.69e-05	0.000501	CcSEcCtD
Triamcinolone—BCHE—Peptide hormone metabolism—LEP—osteoporosis	6.66e-05	0.0055	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	6.66e-05	0.0055	CbGpPWpGaD
Triamcinolone—Fatigue—Estradiol—osteoporosis	6.56e-05	0.00049	CcSEcCtD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.53e-05	0.0054	CbGpPWpGaD
Triamcinolone—Dizziness—Zoledronate—osteoporosis	6.53e-05	0.000488	CcSEcCtD
Triamcinolone—Pain—Estradiol—osteoporosis	6.5e-05	0.000486	CcSEcCtD
Triamcinolone—Nausea—Pamidronate—osteoporosis	6.42e-05	0.00048	CcSEcCtD
Triamcinolone—Dizziness—Conjugated Estrogens—osteoporosis	6.28e-05	0.00047	CcSEcCtD
Triamcinolone—Vomiting—Zoledronate—osteoporosis	6.27e-05	0.000469	CcSEcCtD
Triamcinolone—Feeling abnormal—Estradiol—osteoporosis	6.27e-05	0.000469	CcSEcCtD
Triamcinolone—Rash—Zoledronate—osteoporosis	6.22e-05	0.000465	CcSEcCtD
Triamcinolone—Dermatitis—Zoledronate—osteoporosis	6.22e-05	0.000465	CcSEcCtD
Triamcinolone—Headache—Zoledronate—osteoporosis	6.18e-05	0.000462	CcSEcCtD
Triamcinolone—Vomiting—Conjugated Estrogens—osteoporosis	6.04e-05	0.000452	CcSEcCtD
Triamcinolone—Urticaria—Estradiol—osteoporosis	6.04e-05	0.000452	CcSEcCtD
Triamcinolone—Body temperature increased—Estradiol—osteoporosis	6.01e-05	0.00045	CcSEcCtD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	6e-05	0.00496	CbGpPWpGaD
Triamcinolone—Rash—Conjugated Estrogens—osteoporosis	5.99e-05	0.000448	CcSEcCtD
Triamcinolone—Dermatitis—Conjugated Estrogens—osteoporosis	5.99e-05	0.000448	CcSEcCtD
Triamcinolone—Headache—Conjugated Estrogens—osteoporosis	5.95e-05	0.000445	CcSEcCtD
Triamcinolone—Nausea—Zoledronate—osteoporosis	5.86e-05	0.000438	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	5.86e-05	0.00484	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	5.83e-05	0.00482	CbGpPWpGaD
Triamcinolone—BCHE—Peptide hormone metabolism—POMC—osteoporosis	5.72e-05	0.00472	CbGpPWpGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	5.67e-05	0.00468	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CCT2—osteoporosis	5.65e-05	0.00466	CbGpPWpGaD
Triamcinolone—Nausea—Conjugated Estrogens—osteoporosis	5.64e-05	0.000422	CcSEcCtD
Triamcinolone—Hypersensitivity—Estradiol—osteoporosis	5.6e-05	0.000419	CcSEcCtD
Triamcinolone—BCHE—Peptide hormone metabolism—IGF1—osteoporosis	5.5e-05	0.00454	CbGpPWpGaD
Triamcinolone—Asthenia—Estradiol—osteoporosis	5.46e-05	0.000408	CcSEcCtD
Triamcinolone—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	5.44e-05	0.00449	CbGpPWpGaD
Triamcinolone—Pruritus—Estradiol—osteoporosis	5.38e-05	0.000402	CcSEcCtD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	5.35e-05	0.00442	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	5.3e-05	0.00438	CbGpPWpGaD
Triamcinolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	5.21e-05	0.0043	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	5.19e-05	0.00428	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.08e-05	0.0042	CbGpPWpGaD
Triamcinolone—Dizziness—Estradiol—osteoporosis	5.03e-05	0.000376	CcSEcCtD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.95e-05	0.00409	CbGpPWpGaD
Triamcinolone—Vomiting—Estradiol—osteoporosis	4.84e-05	0.000362	CcSEcCtD
Triamcinolone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	4.83e-05	0.00399	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—TUBA1B—osteoporosis	4.8e-05	0.00396	CbGpPWpGaD
Triamcinolone—Rash—Estradiol—osteoporosis	4.8e-05	0.000359	CcSEcCtD
Triamcinolone—Dermatitis—Estradiol—osteoporosis	4.79e-05	0.000358	CcSEcCtD
Triamcinolone—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	4.79e-05	0.00395	CbGpPWpGaD
Triamcinolone—Headache—Estradiol—osteoporosis	4.76e-05	0.000356	CcSEcCtD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.74e-05	0.00392	CbGpPWpGaD
Triamcinolone—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	4.68e-05	0.00386	CbGpPWpGaD
Triamcinolone—Nausea—Estradiol—osteoporosis	4.52e-05	0.000338	CcSEcCtD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	4.5e-05	0.00371	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IRS2—osteoporosis	4.4e-05	0.00363	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—LEP—osteoporosis	4.3e-05	0.00355	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.96e-05	0.00327	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—ADCY5—osteoporosis	3.92e-05	0.00324	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IRS1—osteoporosis	3.84e-05	0.00317	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—RPL24—osteoporosis	3.84e-05	0.00317	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	3.78e-05	0.00312	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	3.77e-05	0.00312	CbGpPWpGaD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	3.73e-05	0.00308	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	3.72e-05	0.00307	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	3.58e-05	0.00296	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IGF1—osteoporosis	3.56e-05	0.00294	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—LEP—osteoporosis	3.53e-05	0.00291	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	3.51e-05	0.0029	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	3.5e-05	0.00289	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.5e-05	0.00289	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	3.46e-05	0.00286	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.41e-05	0.00281	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—TLN1—osteoporosis	3.37e-05	0.00279	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.37e-05	0.00278	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—REN—osteoporosis	3.24e-05	0.00268	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	3.24e-05	0.00268	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	3.12e-05	0.00258	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	3.12e-05	0.00257	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—U2AF1—osteoporosis	3.11e-05	0.00257	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	3.1e-05	0.00256	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—FDPS—osteoporosis	3.07e-05	0.00253	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PKM—osteoporosis	3.07e-05	0.00253	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.06e-05	0.00253	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	3.06e-05	0.00252	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—ADCY5—osteoporosis	3e-05	0.00248	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PGLS—osteoporosis	2.91e-05	0.0024	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GPD2—osteoporosis	2.91e-05	0.0024	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	2.84e-05	0.00235	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.72e-05	0.00225	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ATIC—osteoporosis	2.66e-05	0.0022	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PNP—osteoporosis	2.66e-05	0.0022	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	2.64e-05	0.00218	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SOST—osteoporosis	2.52e-05	0.00208	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PKM—osteoporosis	2.52e-05	0.00208	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	2.47e-05	0.00204	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ANTXR2—osteoporosis	2.39e-05	0.00198	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PGLS—osteoporosis	2.39e-05	0.00198	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	2.37e-05	0.00196	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	2.32e-05	0.00192	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.32e-05	0.00191	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—RPL24—osteoporosis	2.31e-05	0.00191	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	2.3e-05	0.0019	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	2.29e-05	0.00189	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.27e-05	0.00188	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CA2—osteoporosis	2.26e-05	0.00187	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—OXCT1—osteoporosis	2.26e-05	0.00187	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	2.25e-05	0.00186	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—MGLL—osteoporosis	2.21e-05	0.00182	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TGFB1—osteoporosis	2.13e-05	0.00176	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—FDPS—osteoporosis	2.11e-05	0.00174	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PKM—osteoporosis	2.11e-05	0.00174	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.08e-05	0.00172	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	2.06e-05	0.0017	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GSN—osteoporosis	2.03e-05	0.00168	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—ACE—osteoporosis	2.02e-05	0.00167	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PGLS—osteoporosis	2e-05	0.00165	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GPD2—osteoporosis	2e-05	0.00165	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—osteoporosis	1.99e-05	0.00164	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.98e-05	0.00164	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	1.96e-05	0.00162	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—IDH2—osteoporosis	1.88e-05	0.00155	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.84e-05	0.00152	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ATIC—osteoporosis	1.83e-05	0.00151	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PNP—osteoporosis	1.83e-05	0.00151	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LRP5—osteoporosis	1.77e-05	0.00146	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP27A1—osteoporosis	1.76e-05	0.00146	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MYC—osteoporosis	1.75e-05	0.00145	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	1.75e-05	0.00144	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	1.72e-05	0.00142	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ACP5—osteoporosis	1.72e-05	0.00142	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.69e-05	0.0014	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LRP6—osteoporosis	1.69e-05	0.0014	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	1.66e-05	0.00137	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—osteoporosis	1.63e-05	0.00135	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.63e-05	0.00134	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RPL24—osteoporosis	1.63e-05	0.00134	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LTF—osteoporosis	1.63e-05	0.00134	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IL6—osteoporosis	1.61e-05	0.00133	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.61e-05	0.00133	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TPI1—osteoporosis	1.59e-05	0.00132	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CA2—osteoporosis	1.56e-05	0.00129	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—OXCT1—osteoporosis	1.56e-05	0.00129	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MGLL—osteoporosis	1.52e-05	0.00125	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	1.5e-05	0.00124	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—P4HB—osteoporosis	1.5e-05	0.00124	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GAPDH—osteoporosis	1.47e-05	0.00122	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—RAP1A—osteoporosis	1.43e-05	0.00118	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.43e-05	0.00118	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ACP5—osteoporosis	1.41e-05	0.00116	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	1.39e-05	0.00115	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PSMA2—osteoporosis	1.33e-05	0.0011	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PSMA5—osteoporosis	1.33e-05	0.0011	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL6—osteoporosis	1.32e-05	0.00109	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TPI1—osteoporosis	1.31e-05	0.00108	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—IDH2—osteoporosis	1.29e-05	0.00107	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—LEP—osteoporosis	1.26e-05	0.00104	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.25e-05	0.00103	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—P4HB—osteoporosis	1.23e-05	0.00102	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP27A1—osteoporosis	1.21e-05	0.001	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GAPDH—osteoporosis	1.21e-05	0.000999	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ESR2—osteoporosis	1.19e-05	0.000984	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.19e-05	0.000983	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.19e-05	0.000981	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ACP5—osteoporosis	1.18e-05	0.000975	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.17e-05	0.000962	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ENO1—osteoporosis	1.16e-05	0.000957	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NFATC1—osteoporosis	1.15e-05	0.000949	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PSMA2—osteoporosis	1.14e-05	0.000943	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PSMA5—osteoporosis	1.14e-05	0.000943	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—DKK1—osteoporosis	1.14e-05	0.000941	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.11e-05	0.000916	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—WNT1—osteoporosis	1.1e-05	0.000907	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TPI1—osteoporosis	1.1e-05	0.000906	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—POMC—osteoporosis	1.08e-05	0.000892	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGA—osteoporosis	1.07e-05	0.000882	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGF1—osteoporosis	1.04e-05	0.000858	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—P4HB—osteoporosis	1.03e-05	0.000852	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GAPDH—osteoporosis	1.01e-05	0.000836	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—RAP1A—osteoporosis	9.86e-06	0.000815	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—POMC—osteoporosis	9.78e-06	0.000808	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ENO1—osteoporosis	9.52e-06	0.000786	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—VDR—osteoporosis	9.46e-06	0.000781	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PSMA2—osteoporosis	9.38e-06	0.000775	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PSMA5—osteoporosis	9.38e-06	0.000775	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP19A1—osteoporosis	9.26e-06	0.000765	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PKM—osteoporosis	9.23e-06	0.000762	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—FDPS—osteoporosis	9.23e-06	0.000762	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GPD2—osteoporosis	8.75e-06	0.000722	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PGLS—osteoporosis	8.75e-06	0.000722	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CALCA—osteoporosis	8.74e-06	0.000722	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.6e-06	0.00071	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ATIC—osteoporosis	8e-06	0.000661	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PNP—osteoporosis	8e-06	0.000661	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ENO1—osteoporosis	7.97e-06	0.000658	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KL—osteoporosis	7.94e-06	0.000656	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PSMA2—osteoporosis	7.86e-06	0.000649	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PSMA5—osteoporosis	7.86e-06	0.000649	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	7.81e-06	0.000645	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ADCY5—osteoporosis	7.57e-06	0.000625	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GPX1—osteoporosis	7.54e-06	0.000623	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ESR1—osteoporosis	7.23e-06	0.000597	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—MTHFR—osteoporosis	6.96e-06	0.000575	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—OXCT1—osteoporosis	6.8e-06	0.000562	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CA2—osteoporosis	6.8e-06	0.000562	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MGLL—osteoporosis	6.63e-06	0.000547	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP19A1—osteoporosis	6.37e-06	0.000526	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ADCY5—osteoporosis	6.22e-06	0.000514	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTHFR—osteoporosis	5.72e-06	0.000472	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—IDH2—osteoporosis	5.64e-06	0.000465	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—POMC—osteoporosis	5.57e-06	0.00046	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IRS2—osteoporosis	5.44e-06	0.000449	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.3e-06	0.000438	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ADCY5—osteoporosis	5.21e-06	0.00043	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GPX1—osteoporosis	5.19e-06	0.000429	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ACP5—osteoporosis	5.16e-06	0.000426	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TPI1—osteoporosis	4.79e-06	0.000396	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MTHFR—osteoporosis	4.79e-06	0.000396	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IRS1—osteoporosis	4.75e-06	0.000392	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—P4HB—osteoporosis	4.51e-06	0.000372	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6R—osteoporosis	4.46e-06	0.000369	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GAPDH—osteoporosis	4.42e-06	0.000365	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—RAP1A—osteoporosis	4.31e-06	0.000356	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—POMC—osteoporosis	3.83e-06	0.000316	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MYC—osteoporosis	3.76e-06	0.00031	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ENO1—osteoporosis	3.48e-06	0.000288	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PSMA5—osteoporosis	3.43e-06	0.000283	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PSMA2—osteoporosis	3.43e-06	0.000283	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.78e-06	0.00023	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MYC—osteoporosis	2.64e-06	0.000218	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—osteoporosis	2.64e-06	0.000218	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ADCY5—osteoporosis	2.27e-06	0.000188	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GPX1—osteoporosis	2.27e-06	0.000187	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTHFR—osteoporosis	2.09e-06	0.000173	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—osteoporosis	1.99e-06	0.000164	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—POMC—osteoporosis	1.67e-06	0.000138	CbGpPWpGaD
